On September 9, 2024, the single-dose pre-filled OcuClick syringe for the administration of Eylea HD has received approval from the European Medicines Agency (EMA) and at slightly different times is becoming commercially available in all countries within Europe.

This alternative way to administer the 70μl dose of aflibercept 8 mg is easier, saves time and further enhances safety by cutting down on the preparation steps required by the vial.

In this video, Patricia Udaondo, MD, PhD, shares her thoughts on Eylea HD and the prefilled syringe, a new advancement that will further benefit patients with age-related macular degeneration (AMD) and diabetic macular edema (DME), for which Eylea HD is currently indicated.

Dr. Udaondo is a retina specialist at the Hospital Universitario La Fe de Valencia, is co-director and co-founder of the Aiken Clinic in Valencia and Associate Professor at the University of Valencia.